Articles with public access mandates - Eric R. ProssnitzLearn more
Not available anywhere: 4
A crystalline ready-to-use form of cyclopentadiene
F Krupp, S He, W Frey, C Richert
Synlett 29 (13), 1707-1710, 2018
Mandates: German Research Foundation
Kisspeptin and glucose homeostasis
C Izzi-Engbeaya, TG Hill, JE Bowe
Seminars in Reproductive Medicine 37 (03), 141-146, 2019
Mandates: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Assessment of Metabolic Regulation by EstrogenReceptors
G Sharma, ER Prossnitz
Estrogen Receptors: Methods and Protocols, 383-404, 2022
Mandates: US National Institutes of Health
Assessing Estrogenic Activity of Classical EstrogenReceptor-Binding Compounds
RA Pepermans, ER Prossnitz
Estrogen Receptors: Methods and Protocols, 187-201, 2022
Mandates: US National Institutes of Health
Available somewhere: 123
The G-protein-coupled estrogen receptor GPER in health and disease
ER Prossnitz, M Barton
Nature Reviews Endocrinology 7 (12), 715-726, 2011
Mandates: Swiss National Science Foundation, US National Institutes of Health
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
In vivo effects of a GPR30 antagonist
MK Dennis, R Burai, C Ramesh, WK Petrie, SN Alcon, TK Nayak, ...
Nature chemical biology 5 (6), 421-427, 2009
Mandates: US National Institutes of Health
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
Mandates: US National Institutes of Health
Mechanisms of estrogen signaling and gene expression via GPR30
ER Prossnitz, M Maggiolini
Molecular and cellular endocrinology 308 (1-2), 32-38, 2009
Mandates: US National Institutes of Health
Estrogen biology: new insights into GPER function and clinical opportunities
ER Prossnitz, M Barton
Molecular and cellular endocrinology 389 (1-2), 71-83, 2014
Mandates: Swiss National Science Foundation, US National Institutes of Health
Regulatory role of G protein–coupled estrogen receptor for vascular function and obesity
E Haas, I Bhattacharya, E Brailoiu, M Damjanović, GC Brailoiu, X Gao, ...
Circulation research 104 (3), 288-291, 2009
Mandates: Swiss National Science Foundation, US National Institutes of Health
Full characterization of GPCR monomer–dimer dynamic equilibrium by single molecule imaging
RS Kasai, KGN Suzuki, ER Prossnitz, I Koyama-Honda, C Nakada, ...
Journal of Cell Biology 192 (3), 463-480, 2011
Mandates: US National Institutes of Health
Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors
MR Meyer, DJ Clegg, ER Prossnitz, M Barton
Acta Physiologica 203 (1), 259-269, 2011
Mandates: Swiss National Science Foundation, US National Institutes of Health
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity
MK Dennis, AS Field, R Burai, C Ramesh, WK Petrie, CG Bologa, ...
The Journal of steroid biochemistry and molecular biology 127 (3-5), 358-366, 2011
Mandates: US National Institutes of Health
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
Mandates: US National Institutes of Health, UK Engineering and Physical Sciences …
The G protein–coupled receptor GPR30 inhibits proliferation of estrogen receptor–positive breast cancer cells
EA Ariazi, E Brailoiu, S Yerrum, HA Shupp, MJ Slifker, HE Cunliffe, ...
Cancer research 70 (3), 1184-1194, 2010
Mandates: US National Institutes of Health
International union of basic and clinical pharmacology. XCVII. G protein–coupled estrogen receptor and its pharmacologic modulators
ER Prossnitz, JB Arterburn
Pharmacological reviews 67 (3), 505-540, 2015
Mandates: US National Institutes of Health, Wellcome Trust
GPR30 predicts poor survival for ovarian cancer
HO Smith, H Arias-Pulido, DY Kuo, T Howard, CR Qualls, SJ Lee, ...
Gynecologic oncology 114 (3), 465-471, 2009
Mandates: US National Institutes of Health
GPR30 expression is required for the mineralocorticoid receptor–independent rapid vascular effects of aldosterone
R Gros, Q Ding, LA Sklar, EE Prossnitz, JB Arterburn, J Chorazyczewski, ...
Hypertension 57 (3), 442-451, 2011
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives
M Barton, EJ Filardo, SJ Lolait, P Thomas, M Maggiolini, ER Prossnitz
The Journal of steroid biochemistry and molecular biology 176, 4-15, 2018
Mandates: Swiss National Science Foundation, US National Institutes of Health, German …
Publication and funding information is determined automatically by a computer program